Cenra (3716.TW) Osake Kurssi

Cenra Inc is a Taiwan-based pharmaceutical company headquartered in Taipei City. The company operates in the Health Care sector, specifically within the Pharmaceuticals industry. Cenra Inc completed its initial public offering (IPO) on September 2, 2024, with the ticker symbol 3716.TW and ISIN TW0003716007. The company's business activities include the development, manufacturing, and sales of pharmaceuticals, agricultural and livestock drugs, personal hygiene and health products, and medical instruments. Through its subsidiaries, Cenra Inc offers a range of products including human medicines such as prescription and over-the-counter drugs, as well as disease treatment products. The company also provides medical equipment including blood pressure monitors, blood glucose meters, and artificial joints. Additionally, Cenra Inc develops and sells animal medicines, supplementary feeds, and feed additives for animal treatment, disease prevention, and nutritional supplements. The company's product portfolio also encompasses daily necessities like oral hygiene products (toothpaste, tooth powder, mouthwash), hand cleansers, dry hand sanitizers, shower gels, medicated soaps, and skin care products. Cenra Inc does not engage in general investment-related businesses as previously mentioned in untrusted sources; its core operations are focused on pharmaceuticals and health-related products.